On Monday, Pfizer Inc (NYSE: PFE) opened higher 2.95% from the last session, before settling in for the closing price of $26.09. Price fluctuations for PFE have ranged from $24.48 to $31.54 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 19.51%. Company’s average yearly earnings per share was noted 58.35% at the time writing. With a float of $5.66 billion, this company’s outstanding shares have now reached $5.67 billion.
Let’s determine the extent of company efficiency that accounts for 88000 employees. In terms of profitability, gross margin is 59.1%, operating margin of 16.85%, and the pretax margin is 6.49%.
Pfizer Inc (PFE) Insider Activity
A key investor’s attitude towards the stock of the Drug Manufacturers – General industry is another important factor to consider. The insider ownership of Pfizer Inc is 0.04%, while institutional ownership is 67.51%. The most recent insider transaction that took place on Oct 30 ’24, was worth 28,240. In this transaction Director of this company bought 1,000 shares at a rate of $28.24, taking the stock ownership to the 10,000 shares. Before that another transaction happened on Aug 13 ’24, when Company’s SVP & Controller sold 5,154 for $28.66, making the entire transaction worth $147,714. This insider now owns 8,582 shares in total.
Pfizer Inc (PFE) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.72 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 58.35% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 17.76% during the next five years compared to -27.43% drop over the previous five years of trading.
Pfizer Inc (NYSE: PFE) Trading Performance Indicators
Check out the current performance indicators for Pfizer Inc (PFE). In the past quarter, the stock posted a quick ratio of 0.73. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.53. Likewise, its price to free cash flow for the trailing twelve months is 18.50.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.74, a number that is poised to hit 0.45 in the next quarter and is forecasted to reach 2.89 in one year’s time.
Technical Analysis of Pfizer Inc (PFE)
Looking closely at Pfizer Inc (NYSE: PFE), its last 5-days average volume was 40.91 million, which is a jump from its year-to-date volume of 35.85 million. As of the previous 9 days, the stock’s Stochastic %D was 54.29%. Additionally, its Average True Range was 0.55.
During the past 100 days, Pfizer Inc’s (PFE) raw stochastic average was set at 40.00%, which indicates a significant decrease from 58.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 22.40% in the past 14 days, which was lower than the 23.47% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $26.07, while its 200-day Moving Average is $27.87. However, in the short run, Pfizer Inc’s stock first resistance to watch stands at $27.16. Second resistance stands at $27.46. The third major resistance level sits at $27.95. If the price goes on to break the first support level at $26.37, it is likely to go to the next support level at $25.88. Should the price break the second support level, the third support level stands at $25.58.
Pfizer Inc (NYSE: PFE) Key Stats
There are currently 5,666,990K shares outstanding in the company with a market cap of 152.22 billion. Presently, the company’s annual sales total 58,496 M according to its annual income of 2,119 M. Last quarter, the company’s sales amounted to 17,702 M and its income totaled 4,465 M.
